Utah Inland Port Authority (UIPA) is building the foundation for Utah’s future as a life sciences and biotech logistics powerhouse. As the only statewide inland port authority in the U.S., UIPA is developing a network of project areas to support advanced manufacturing and distribution—specifically tailored to high-growth industries like biotechnology, pharmaceuticals, medical devices, and clean energy. Utah is home to a highly educated workforce, a robust life sciences cluster, and one of the most efficient regulatory environments in the country. UIPA is leveraging these strengths by working with local governments, industry partners, and developers to create project areas that offer access to logistics infrastructure, proximity to academic universities, and opportunities for sustainable growth. Many of these sites are in active development, including Salt Lake City’s Northwest Quadrant where plans are underway to meet the specific needs of biotech and life sciences organizations. At BIO, UIPA is seeking partners ready to expand or relocate in a business-friendly state with the infrastructure, talent, and leadership to support the future of health innovation and global distribution. | Utah Inland Port Authority: Scaling Bio-Manufacturing from Lab to Launch. Utah is a premier destination for life sciences, and UIPA is the engine driving its manufacturing evolution. As the nation’s only statewide port authority, we provide a network of project areas specifically engineered for bio-manufacturing, pharmaceuticals, and medical device production. We bridge the gap between innovation and scale by offering: Specialized Infrastructure: Shovel-ready sites designed for the high-utility and specialized logistics demands of bio-production. Strategic Access: A statewide footprint with direct proximity to Utah’s world-class research universities and a highly skilled technical workforce. Operational Speed: An efficient, business-friendly regulatory environment that accelerates your time-to-market. Visit us at BIO to see why Utah is the ideal home for your next manufacturing expansion or relocation.
Sikich
Sikich LLP is a business and technology consultancy who’s close to 1,500 team members provide advisory, consulting, and technology services to clients in life sciences, manufacturing, professional services, and other industries. The company’s life sciences practice spans the industry and supports more than 200 life sciences clients, including biotechnology and biopharmaceutical companies, CROs, and lab diagnostic companies. As a leading life science technology consultant, we can help you streamline operations and ensure compliance, allowing stakeholders to do what they do best: develop new medicines for patients who need them. | At Sikich, we empower life sciences organizations through strategic planning, regulatory expertise, and digital modernization. From inception to commercialization, we specialize in planning, regulatory, quality, and compliance, leveraging cutting-edge technologies like Oracle NetSuite, Honeywell’s TrackWise Digital, and Kneat’s solutions to streamline operations and accelerate innovation. Our tailored approach combines deep industry knowledge with advanced digital tools, ensuring compliance, enhancing efficiency, and reducing time-to-market for life-changing therapies. A focus on built in audit trails, roles-based control and automated reporting ensure compliance with FDA 21 CFR Part 11, SOX and EU Annex 11. With a commitment to precision, integrity, and transformation, we help companies navigate complex regulatory landscapes and embrace the future of life sciences with confidence. Plan smarter. Modernize faster. Innovate with impact.
EUROBIOMED
Eurobiomed is the one of the leading healthtech innovation networks of France. It has been federating key innovative players from the public and the private sectors, since 2009. Eurobiomed is labeled by the State as the health competitiveness cluster for both the Occitania and the South Regions. Since its creation, Eurobiomed has supported 320 R&D projects. The latter have been financed through various European, national and regional calls for projects, representing more than 1.5 billion euros of investment, including 500 million euros of public aid. Behind the success of Eurobiomed lies the relentless work of an operational team with complementary scientific and managerial skills, as well as the nationally recognized expertise of its Strategic Project Council (SPC) and its pool of carefully selected external consultants. At Eurobiomed, passion and commitment to empowering future healthtech leaders are our daily fuel ! | Eurobiomed is the one of the leading healthtech innovation networks of France. It has been federating key innovative players from the public and the private sectors, since 2009. Eurobiomed is labeled by the State as the health competitiveness cluster for both the Occitania and the South Regions. Since its creation, Eurobiomed has supported 390 R&D projects. The latter have been financed through various European, national and regional calls for projects, representing more than 1.5 billion euros of investment, including 720 million euros of public aid. Behind the success of Eurobiomed lies the relentless work of an operational team with complementary scientific and managerial skills, as well as the nationally recognized expertise of its Strategic Project Council (SPC) and its pool of carefully selected external consultants. At Eurobiomed, passion and commitment to empowering future healthtech leaders are our daily fuel ! | Eurobiomed brings together the healthcare innovation community in the south of France, and federates the best experts in the sector, to support its companies in their development and turn its brightest stars into world champions. Created in 2005, Eurobiomed helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d’Azur and Occitanie/Pyrénées-Méditerranée regions at the forefront of innovation. Eurobiomed brings together all healthcare players, both public and private, researchers, practitioners, technological innovation centers, financiers, and companies. Its aim is to promote the growth and projects of innovative healthcare companies in the region, by supporting their strategy and development needs through tailor-made support, personalized mentoring, etc. | Eurobiomed brings together the healthcare innovation community in the south of France, and federates the best experts in the sector, to support its companies in their development and turn its brightest stars into world champions. Key Figures (2024) – Over four hundred members, representing more than 80% of innovative healthcare companies in the south of France. – More than fifty events organized for our community by 2025. – 129.9M€ of public funding raised by our members in 2024. – 134.5M€ of private funding raised by our members in 2024. – More than €1.5M in public funding obtained since the creation of Eurobiomed in 2005, enabling the financing of over four hundred innovative projects. Created in 2005, Eurobiomed helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d’Azur and Occitanie/Pyrénées-Méditerranée regions at the forefront of innovation. Eurobiomed brings together all healthcare players, both public and private, researchers, practitioners, technological innovation centers, financiers, and companies. Its aim is to promote the growth and projects of innovative healthcare companies in the region, by supporting their strategy and development needs through tailor-made support, personalized mentoring, etc. Over the past 20 years, Eurobiomed has enabled its members to optimize their financing strategies. Over €1.5 billion in public funding has been obtained by the Eurobiomed community in response to regional, national, and European calls for projects, enabling the financing of more than four hundred innovation projects. From prevention to care, from diagnostics to personalized medicine, from medical equipment to digital health, from immunology to dermatology, Eurobiomed supports French and European public strategies for economic development and helps to anchor France among the world leaders in healthcare innovation. Based in Nice, Sophia Antipolis, Marseille, Montpellier, and Toulouse, Eurobiomed currently employs around twenty people. For further information: https://www.eurobiomed.org/
Catawba County Economic Development Corp.
The Catawba County Economic Development Corporation (EDC) serves as the lead organization for business recruitment, expansion, and strategic investment in Catawba County, North Carolina—one of the fastest-growing advanced manufacturing and innovation hubs in the Charlotte Region. Positioned along the I-40 corridor with direct access to Interstate 77 and Charlotte Douglas International Airport, Catawba County offers companies a highly competitive environment supported by world-class logistics, a skilled workforce, and a strong culture of industry collaboration. In recent years, the region has seen growing momentum in life sciences and biotechnology, building on North Carolina’s nationally recognized leadership in the sector. Catawba County is advancing new opportunities through investments in workforce training, partnerships with regional universities and community colleges, and emerging infrastructure designed to support biomanufacturing, advanced materials, and next-generation life science technologies. With a legacy of precision manufacturing, polymers, and advanced materials expertise, the community is well positioned to support companies developing therapies, diagnostics, and bioprocess technologies. New innovation assets, workforce initiatives, and industry partnerships are helping connect the Charlotte Region’s manufacturing strength with North Carolina’s broader life sciences ecosystem. The Catawba County EDC works closely with companies to provide site selection assistance, workforce solutions, and tailored project support, helping life sciences firms scale efficiently and succeed in one of the Southeast’s most dynamic growth corridors.
BIO Business Solutions®
BIO Business Solutions is the largest cost-savings purchasing program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life sciences companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, regulatory services, HR and much more. BIO helped 4,700 life science companies save over $705 million last year alone. | BIO Business Solutions is the largest cost-savings program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life science companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, cleanroom services, HR and much more. Every year, BIO helps nearly 5,000 companies save over $700 million. | BIO Business Solutions is the largest cost savings program for the life sciences industry, operated by BIO. BIO Business Solutions negotiates significant volume-based discounts, favorable terms, and other benefits on products and services with industry leading suppliers on behalf of BIO members and the members of state and regional biotech associations. Learn more at bio.org/save.